{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T16:40:24Z","timestamp":1743007224827,"version":"3.40.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,26]]},"DOI":"10.7759\/cureus.81236","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T16:09:34Z","timestamp":1743005374000},"source":"Crossref","is-referenced-by-count":0,"title":["Managing Ifosfamide-Induced Arginine Vasopressin Resistance: Diagnostic and Treatment Strategies"],"prefix":"10.7759","author":[{"given":"Avia A","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arslan I","family":"Pir Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupam","family":"Ruchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozina","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142030-00006","article-title":"Ifosfamide\/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer","volume":"42","author":"Dechant KL","year":"1991","unstructured":"Dechant KL, Brogden RN, Pilkington T, Faulds D. Ifosfamide\/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs. 1991, 42:428-67. 10.2165\/00003495-199142030-00006","journal-title":"Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1043","article-title":"Ifosfamide-induced nephrotoxicity: mechanism and prevention","volume":"66","author":"Nissim I","year":"2006","unstructured":"Nissim I, Horyn O, Daikhin Y, Nissim I, Luhovyy B, Phillips PC, Yudkoff M. Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res. 2006, 66:7824-31. 10.1158\/0008-5472.CAN-06-1043","journal-title":"Cancer Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfz183","article-title":"Ifosfamide nephrotoxicity in adult patients","volume":"13","author":"Ensergueix G","year":"2020","unstructured":"Ensergueix G, Pallet N, Joly D, et al.. Ifosfamide nephrotoxicity in adult patients. Clin Kidney J. 2020, 13:660-5. 10.1093\/ckj\/sfz183","journal-title":"Clin Kidney J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.89","article-title":"Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus","volume":"11","author":"Bockenhauer D","year":"2015","unstructured":"Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol. 2015, 11:576-88. 10.1038\/nrneph.2015.89","journal-title":"Nat Rev Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e04-04-0337","article-title":"Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells","volume":"15","author":"Robben JH","year":"2004","unstructured":"Robben JH, Knoers NV, Deen PM. Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells. Mol Biol Cell. 2004, 15:5693-9. 10.1091\/mbc.e04-04-0337","journal-title":"Mol Biol Cell"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4507","article-title":"Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study","volume":"100","author":"Timper K","year":"2015","unstructured":"Timper K, Fenske W, K\u00fchn F, et al.. Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study. J Clin Endocrinol Metab. 2015, 100:2268-74. 10.1210\/jc.2014-4507","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5414\/CNCS110589","article-title":"Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin","volume":"9","author":"Sohail MA","year":"2021","unstructured":"Sohail MA, Hassanein M, Rincon-Choles H. Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin. Clin Nephrol Case Stud. 2021, 9:87-92. 10.5414\/CNCS110589","journal-title":"Clin Nephrol Case Stud"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3947","article-title":"Partial Fanconi syndrome Induced by ifosfamide","volume":"11","author":"Das S","year":"2019","unstructured":"Das S, Valencia DN, Fershko A. Partial Fanconi syndrome Induced by ifosfamide. Cureus. 2019, 11:e3947. 10.7759\/cureus.3947","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2014.29.2.246","article-title":"Ifosfamide-induced Fanconi syndrome with diabetes insipidus","volume":"29","author":"Leem AY","year":"2014","unstructured":"Leem AY, Kim HS, Yoo BW, Kang BD, Kim MH, Rha SY, Kim HS. Ifosfamide-induced Fanconi syndrome with diabetes insipidus. Korean J Intern Med. 2014, 29:246-9. 10.3904\/kjim.2014.29.2.246","journal-title":"Korean J Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.182","article-title":"The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives","volume":"13","author":"Cherqui S","year":"2017","unstructured":"Cherqui S, Courtoy PJ. The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives. Nat Rev Nephrol. 2017, 13:115-31. 10.1038\/nrneph.2016.182","journal-title":"Nat Rev Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103%2F2230-8210.172273","article-title":"Diabetes insipidus: the other diabetes","volume":"20","author":"Kalra S","year":"2016","unstructured":"Kalra S, Zargar AH, Jain SM, et al.. Diabetes insipidus: the other diabetes. Indian J Endocrinol Metab. 2016, 20:9-21. 10.4103%2F2230-8210.172273","journal-title":"Indian J Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-023-00829-z","article-title":"A case of ifosfamide-induced acute kidney injury, Fanconi syndrome, and nephrogenic diabetes insipidus","volume":"13","author":"Hoang S","year":"2024","unstructured":"Hoang S, Pujar T, Bellorin-Font E, Edwards JC, Miyata KN. A case of ifosfamide-induced acute kidney injury, Fanconi syndrome, and nephrogenic diabetes insipidus. CEN Case Rep. 2024, 13:194-8. 10.1007\/s13730-023-00829-z","journal-title":"CEN Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/294142-managing-ifosfamide-induced-arginine-vasopressin-resistance-diagnostic-and-treatment-strategies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T16:09:36Z","timestamp":1743005376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/294142-managing-ifosfamide-induced-arginine-vasopressin-resistance-diagnostic-and-treatment-strategies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.81236","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,26]]}}}